iTeos Therapeutics
Stock Forecast, Prediction & Price Target
iTeos Therapeutics Financial Estimates
iTeos Therapeutics Revenue Estimates
iTeos Therapeutics EBITDA Estimates
iTeos Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $344.77M N/A | $267.63M -22.37% | $12.59M -95.29% | Avg: $8.12M Low: $1.27M High: $14.95M avg. -35.52% | Avg: $116.07M Low: $23.93M High: $208.20M avg. 1329.35% | Avg: $153.31M Low: $31.62M High: $274.99M avg. 32.08% | Avg: $332.45M Low: $68.56M High: $596.29M avg. 116.83% |
Net Income
% change YoY
| $214.52M N/A | $96.65M -54.94% | $-112.64M -216.54% | Avg: $-240.83M Low: $-298.62M High: $-113.82M avg. -113.80% | Avg: $-164.26M Low: $-256.42M High: $55.07M avg. 31.79% | Avg: $-96.96M Low: $-196.99M High: $3.09M avg. 40.97% | Avg: $15.25M Low: $-486.59K High: $31.00M avg. 115.73% |
EBITDA
% change YoY
| $255.68M N/A | $130.39M -49.00% | $-151.10M -215.88% | Avg: $3.62M Low: $570.36K High: $6.66M avg. 102.39% | Avg: $51.74M Low: $10.67M High: $92.80M avg. 1329.35% | Avg: $68.34M Low: $14.09M High: $122.58M avg. 32.08% | Avg: $148.19M Low: $30.56M High: $265.80M avg. 116.83% |
EPS
% change YoY
| $6.1 N/A | $2.72 -55.40% | -$3.15 -215.80% | Avg: -$5.75 Low: -$8.35 High: -$3.18 avg. -82.68% | Avg: -$3.43 Low: -$7.17 High: $1.54 avg. 40.43% | Avg: -$2.71 Low: -$5.51 High: $0.09 avg. 20.89% | Avg: $0.43 Low: -$0.01 High: $0.87 avg. 115.73% |
Operating Expenses
% change YoY
| $89.69M N/A | $138.04M 53.90% | $163.69M 18.58% | Avg: $10.20M Low: $1.60M High: $18.79M avg. -93.76% | Avg: $145.86M Low: $30.08M High: $261.62M avg. 1329.35% | Avg: $192.66M Low: $39.73M High: $345.56M avg. 32.08% | Avg: $417.75M Low: $86.15M High: $749.30M avg. 116.83% |
FAQ
What is iTeos Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 18.67% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -298.62M, average is -240.83M and high is -113.82M.
What is iTeos Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 360.68% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $1.27M, average is $8.12M and high is $14.95M.
What is iTeos Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 23.59% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$8.35, average is -$5.75 and high is $-3.18.
What is the best performing analyst?
In the last twelve months analysts have been covering iTeos Therapeutics stock. The most successful analyst is Swayampakula Ramakanth.